Search research articles
Contact Us
Filters
Showing results (31-40 of 71) with videos related to
Page
of 8
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 30, 2013
HER2 staining intensity in HER2-positive disease: relationship with FISH amplification and clinical outcome in the HERA trial of adjuvant trastuzumab
L Zabaglo, O Stoss, J Rüschoff, et al.
Anticancer Research
|
April 1, 2009
Effects of epoetin-alpha on quality of life of cancer patients with solid tumors receiving chemotherapy
C Christodoulou, U Dafni, G Aravantinos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 26, 2022
Effectiveness of PD-(L)1 inhibitors alone or in combination with platinum-doublet chemotherapy in first-line (1L) non-squamous non-small-cell lung cancer (Nsq-NSCLC) with PD-L1-high expression using real-world data
M Pérol, E Felip, U Dafni, et al.
Controlled Clinical Trials
|
December 1, 1993
Performance evaluation in multicenter clinical trials: development of a model by the AIDS Clinical Trials Group
L L Rosendorf, U Dafni, D A Amato, et al.
The New England Journal of Medicine
|
May 8, 1998
Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team
C D Hall, U Dafni, D Simpson, et al.
Sleep
|
May 1, 1996
Effects of low energy emission therapy in chronic psychophysiological insomnia
B Pasche, M Erman, R Hayduk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 25, 2024
Efficacy of TIL therapy in advanced cutaneous melanoma in the current immuno-oncology era: updated systematic review and meta-analysis
S Martín-Lluesma, I M Svane, U Dafni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 26, 2017
ESMO-Magnitude of Clinical Benefit Scale version 1.1
N I Cherny, U Dafni, J Bogaerts, et al.
Bone Marrow Transplantation
|
November 21, 2007
High-dose melphalan and autologous stem cell transplantation as consolidation treatment in patients with chemosensitive ovarian cancer: results of a single-institution randomized trial
C Papadimitriou, U Dafni, A Anagnostopoulos, et al.
ESMO Open
|
December 1, 2016
ESMO - Magnitude of Clinical Benefit Scale V.1.0 questions and answers
N I Cherny, R Sullivan, U Dafni, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 71) with videos related to
Sort By:
Page
of 8
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 30, 2013
HER2 staining intensity in HER2-positive disease: relationship with FISH amplification and clinical outcome in the HERA trial of adjuvant trastuzumab
L Zabaglo, O Stoss, J Rüschoff, et al.
Anticancer Research
|
April 1, 2009
Effects of epoetin-alpha on quality of life of cancer patients with solid tumors receiving chemotherapy
C Christodoulou, U Dafni, G Aravantinos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 26, 2022
Effectiveness of PD-(L)1 inhibitors alone or in combination with platinum-doublet chemotherapy in first-line (1L) non-squamous non-small-cell lung cancer (Nsq-NSCLC) with PD-L1-high expression using real-world data
M Pérol, E Felip, U Dafni, et al.
Controlled Clinical Trials
|
December 1, 1993
Performance evaluation in multicenter clinical trials: development of a model by the AIDS Clinical Trials Group
L L Rosendorf, U Dafni, D A Amato, et al.
The New England Journal of Medicine
|
May 8, 1998
Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. AIDS Clinical Trials Group 243 Team
C D Hall, U Dafni, D Simpson, et al.
Sleep
|
May 1, 1996
Effects of low energy emission therapy in chronic psychophysiological insomnia
B Pasche, M Erman, R Hayduk, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 25, 2024
Efficacy of TIL therapy in advanced cutaneous melanoma in the current immuno-oncology era: updated systematic review and meta-analysis
S Martín-Lluesma, I M Svane, U Dafni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 26, 2017
ESMO-Magnitude of Clinical Benefit Scale version 1.1
N I Cherny, U Dafni, J Bogaerts, et al.
Bone Marrow Transplantation
|
November 21, 2007
High-dose melphalan and autologous stem cell transplantation as consolidation treatment in patients with chemosensitive ovarian cancer: results of a single-institution randomized trial
C Papadimitriou, U Dafni, A Anagnostopoulos, et al.
ESMO Open
|
December 1, 2016
ESMO - Magnitude of Clinical Benefit Scale V.1.0 questions and answers
N I Cherny, R Sullivan, U Dafni, et al.
Page
of 8